(Q38203447)

30 August 2017

title

What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients (English)

1 reference

30 August 2017

1 reference

1 reference

Luis L Ostrosky-Zeichner

series ordinal

2

object named as

Luis Ostrosky-Zeichner

1 reference

30 August 2017

Cristóbal León

1

1 reference

30 August 2017

Mindy Schuster

series ordinal

3

1 reference

30 August 2017

publication date

10 April 2014

1 reference

30 August 2017

published in

Intensive Care Medicine

1 reference

30 August 2017

volume

40

1 reference

30 August 2017

issue

6

1 reference

30 August 2017

page(s)

808-819

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-014-3281-0

30 August 2017

exact match

0 references

cites work

International study of the prevalence and outcomes of infection in intensive care units

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Candida spp. colonization significance in critically ill medical patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

[Laboratory diagnosis of fungal infection diseases].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

[Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Systemic antifungal therapy in critically ill patients without invasive fungal infection*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Early treatment of candidemia in adults: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Epidemiological trends in nosocomial candidemia in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Effect of antifungal therapy timing on mortality in cancer patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Septic shock attributed to Candida infection: importance of empiric therapy and source control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Candida infections of medical devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

The microbiology of postoperative peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Diagnosis of invasive candidiasis in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Candida colonization and subsequent infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Invasive fungal infections: biomarkers and molecular approaches to diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Evolving role of early antifungals in the adult intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

PCR-based diagnosis of human fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

PCR diagnosis of invasive candidiasis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3281-0

β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis

21 January 2018

1 reference

12 December 2020

Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital

1 reference

12 December 2020

The diagnostic value of fungal surveillance cultures in critically ill patients

1 reference

12 December 2020

Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome

1 reference

12 December 2020

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey

1 reference

12 December 2020

Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study

1 reference

12 December 2020

Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?

1 reference

12 December 2020

Candida as a risk factor for mortality in peritonitis

1 reference

12 December 2020

A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection

1 reference

12 December 2020

Secular trends in candidemia-related hospitalization in the United States, 2000-2005

1 reference

12 December 2020

The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients

1 reference

12 December 2020

Economic impact of Candida colonization and Candida infection in the critically ill patient

1 reference

12 December 2020

Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida

1 reference

12 December 2020

Value of β-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions

1 reference

12 December 2020

10.1007/S00134-014-3281-0

Identifiers

DOI

1 reference

30 August 2017

1 reference